ID

18405

Description

Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01305967

Link

https://clinicaltrials.gov/show/NCT01305967

Keywords

Versions (1)
  1. 11/3/16 11/3/16 -
Uploaded on

November 3, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non Small Cell Lung Cancer NCT01305967

English

Eligibility Non Small Cell Lung Cancer NCT01305967

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age of 18-70 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
patients with histologically or cytologically confirmed non-small cell lung cancer
Description

Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0007131
patients who had failed more than 1 cycle of standard therapy with advanced or metasatic stage not available to any of resectable surgery or radiotherapy.
Description

Standard of Care Course Quantity failed | advanced disease | Neoplasm Metastasis | Malignant Neoplasm Resectable | Operative Surgical Procedures | Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C2936643
UMLS CUI [1,2]
C0750729
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0231175
UMLS CUI [2]
C0679246
UMLS CUI [3]
C0027627
UMLS CUI [4,1]
C0006826
UMLS CUI [4,2]
C1514888
UMLS CUI [5]
C0543467
UMLS CUI [6]
C1522449
patients with measurable lesions
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
eatern cooperative oncolgy group status 0 to 2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy >/= 5 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
patients with adequate organ(heart, kidney, liver)and bone marrow function, as defined by
Description

Organ function | Cardiac function | Renal function | Liver function | Bone Marrow function

Data type

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C0232164
UMLS CUI [3]
C0232804
UMLS CUI [4]
C0232741
UMLS CUI [5,1]
C0005953
UMLS CUI [5,2]
C0031843
1. absolute neutrophil count >/= 1.5 x 10^9/l, platelet count >/= 100 x 10^9/l
Description

Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
2. total bilirubin </= upper limit of normal
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
3. aspartate aminotransferase and/or alanine aminotransferase </= 2 x upeer limit of normal
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
4. creatinine </= 1.5 x upeer limit of normal
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
patients who have signed the informed consent form.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
female volunteers admitted to the study must be using a reliable means of contraception
Description

Gender Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
received radiation therapy within 6 weeks before randomization
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449
known brain or spinal cord metastases
Description

Metastatic malignant neoplasm to brain | Spinal Cord Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2,1]
C0037925
UMLS CUI [2,2]
C0027627
have acute infection
Description

Communicable Disease

Data type

boolean

Alias
UMLS CUI [1]
C0009450
have active infection or serious concomitant systemic disorder incompatible with the study
Description

Communicable Disease Inconsistent Clinical Trial | Systemic disease Serious Inconsistent Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0442809
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0442809
UMLS CUI [2,4]
C0008976
presence or history of malignancy other than non-small cell lung cancer
Description

Malignant Neoplasms | Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007131
have severe neurologic or psychological disorder
Description

nervous system disorder | Mental disorder

Data type

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0004936
patients who have to receive other chemo-radiotherapy or immunotherapy
Description

Chemoradiotherapy | Immunotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0436307
UMLS CUI [2]
C0021083
patients who have received chemotherapy within the previous 30 days
Description

Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
patients who are candidates for combined modality treatment.
Description

Indication Combined Modality Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0009429
patients who have participated in a clinical study within the previous 30 days
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
Back to the top of the page

Similar models

Eligibility Non Small Cell Lung Cancer NCT01305967

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age of 18-70 years
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma
Item
patients with histologically or cytologically confirmed non-small cell lung cancer
boolean
C0007131 (UMLS CUI [1])
Standard of Care Course Quantity failed | advanced disease | Neoplasm Metastasis | Malignant Neoplasm Resectable | Operative Surgical Procedures | Therapeutic radiology procedure
Item
patients who had failed more than 1 cycle of standard therapy with advanced or metasatic stage not available to any of resectable surgery or radiotherapy.
boolean
C2936643 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C0679246 (UMLS CUI [2])
C0027627 (UMLS CUI [3])
C0006826 (UMLS CUI [4,1])
C1514888 (UMLS CUI [4,2])
C0543467 (UMLS CUI [5])
C1522449 (UMLS CUI [6])
Measurable Disease
Item
patients with measurable lesions
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eatern cooperative oncolgy group status 0 to 2.
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >/= 5 months
boolean
C0023671 (UMLS CUI [1])
Organ function | Cardiac function | Renal function | Liver function | Bone Marrow function
Item
patients with adequate organ(heart, kidney, liver)and bone marrow function, as defined by
boolean
C0678852 (UMLS CUI [1])
C0232164 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
C0005953 (UMLS CUI [5,1])
C0031843 (UMLS CUI [5,2])
Absolute neutrophil count | Platelet Count measurement
Item
1. absolute neutrophil count >/= 1.5 x 10^9/l, platelet count >/= 100 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Serum total bilirubin measurement
Item
2. total bilirubin </= upper limit of normal
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
3. aspartate aminotransferase and/or alanine aminotransferase </= 2 x upeer limit of normal
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Creatinine measurement, serum
Item
4. creatinine </= 1.5 x upeer limit of normal
boolean
C0201976 (UMLS CUI [1])
Informed Consent
Item
patients who have signed the informed consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Gender Contraceptive methods
Item
female volunteers admitted to the study must be using a reliable means of contraception
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
received radiation therapy within 6 weeks before randomization
boolean
C1522449 (UMLS CUI [1])
Metastatic malignant neoplasm to brain | Spinal Cord Neoplasm Metastasis
Item
known brain or spinal cord metastases
boolean
C0220650 (UMLS CUI [1])
C0037925 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Communicable Disease
Item
have acute infection
boolean
C0009450 (UMLS CUI [1])
Communicable Disease Inconsistent Clinical Trial | Systemic disease Serious Inconsistent Clinical Trial
Item
have active infection or serious concomitant systemic disorder incompatible with the study
boolean
C0009450 (UMLS CUI [1,1])
C0442809 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0442809 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
Malignant Neoplasms | Non-Small Cell Lung Carcinoma
Item
presence or history of malignancy other than non-small cell lung cancer
boolean
C0006826 (UMLS CUI [1])
C0007131 (UMLS CUI [2])
nervous system disorder | Mental disorder
Item
have severe neurologic or psychological disorder
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
Chemoradiotherapy | Immunotherapy
Item
patients who have to receive other chemo-radiotherapy or immunotherapy
boolean
C0436307 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
Chemotherapy
Item
patients who have received chemotherapy within the previous 30 days
boolean
C0392920 (UMLS CUI [1])
Indication Combined Modality Therapy
Item
patients who are candidates for combined modality treatment.
boolean
C3146298 (UMLS CUI [1,1])
C0009429 (UMLS CUI [1,2])
Study Subject Participation Status
Item
patients who have participated in a clinical study within the previous 30 days
boolean
C2348568 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial